Navigation Links
Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against Dr. Yamanaka for Deception
Date:5/15/2013

search on the life science forefront. However, Dr. Xu believes that Dr. Yamanaka has steered these professionals down the wrong path. For example, Dr. Xu believes that even the US government was misled into Dr. Yamanaka's hype when the 2008 state of the union address mentioned favoring a way to reprogram adult skin cells to act like embryonic stem cells, as claimed by Dr. Yamanaka. Dr. Xu believes hundreds of millions in taxpayers' money has been wasted in funding such false science.

The Nobel Assembly granted Dr. Yamanaka the Prize in Physiology or Medicine in 2012, acclaiming his artificially transgenic cells created human regenerative potential. Considering the foreseeable consequences threatening human lives, Dr. Xu is working to stop such deception through the legal process.

Dr. Yamanaka labeled his artificial cell produced by oncogene transferring as "somatic cell induction into pluripotent stem cells", i.e. he claimed his artificially transgenic cell study in the name of the plaintiff's patented technology and called it iPSC in short, which was quickly endorsed and followed by a group of prestigious scientists expecting to solve the ethic issue of embryonic stem cell study.

This term used by Dr. Yamanaka is the core of Dr. Xu's patents, including US Patent 6991813 and Dr. Xu alleges that Dr. Yamanaka's study actually has nothing to do with stem cell. Dr. Yamanaka admitted in his article published in Cell Stem Cell magazine in 2012 that he didn't obtain natural pluripotent stem cells by somatic cell induction. According to Dr. Xu, it is critical to ask why such a ridiculous scientific scam has been prevailing worldwide for the past few years.

Human somatic cell induction into pluripotent stem cell is the core content of the Dr. Xu's patented scientific route of "regeneration of damaged organs" and has been accomplished in clinical app
'/>"/>

SOURCE Mebo International; Ardent Law Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dr. Rongxiang Xu, Owner of Patented Technology to Regenerate Damaged Organs, Announces Lawsuit Against 2012 Nobel Laureate Dr. Shinya Yamanaka
2. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against 2012 Nobel Laureate Dr. Yamanaka for Deception
3. Enbrel® (etanercept) Patent Issued
4. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
5. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
6. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
7. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
8. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications
9. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
10. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
11. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that ... County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is ... from and how agriculture impacts their daily lives. This unique exhibit also features a ...
(Date:7/30/2015)... TX, USA (PRWEB) , ... July 30, 2015 ... ... and microsystems, has appointed Francois Vieillard as Sales & Marketing Director. , ... positions, Francois Vieillard will be responsible for reinforcing Tronics’ business development activities worldwide. ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... field clinical study of its canine osteoarthritis stem cell product, currently under development ... City, KS) and will be marketed in the US by Aratana. This product, ...
(Date:7/30/2015)... customers across the globe, ISN improves the efficiency and effectiveness of contractor management systems. ... and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Headquartered in Dallas, TX , ISN has additional offices in ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3
... Burrill Merchant Banking acted as,exclusive financial advisor to ... with Nycomed.,Under the terms of the agreement, NPS ... Nycomed for the treatment of gastrointestinal disorders., ... the treatment of,short-bowel syndrome (SBS). SBS can result ...
... Advancement; CAMVIA Momentum Building Toward 2009 ... ... VPHM ) today announced Michel de Rosen, ViroPharma,s president and,chief executive ... update during the 26th Annual JPMorgan Healthcare,Conference. As previously announced, this presentation ...
... Jan. 9 Quintiles,Transnational Corp. today announced the ... Operations for the company,s Public Health and,Government Services ... diseases and vaccine product development. He will report ... Officer, and Head,of the Public Health and Government ...
Cached Biology Technology:Burrill Merchant Banking Advises NPS on Phase III Licensing Agreement 2ViroPharma Provides 2008 Outlook 2ViroPharma Provides 2008 Outlook 3ViroPharma Provides 2008 Outlook 4ViroPharma Provides 2008 Outlook 5ViroPharma Provides 2008 Outlook 6Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit 2
(Date:7/31/2015)... 2015 BGI llevará a cabo la 10ª Conferencia ... 25 de octubre de 2015, en Shenzhen, ... décimo aniversario este año. Desde su inauguración en 2006, ... anuales más influyentes del mundo en los campos de ... más dinámicas, entusiastas y amenas. ICG-10 se ...
(Date:7/31/2015)... , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... it has filed provisional patent 62/198989 for ... invention highlights a method to advance crypto-currencies such as ... introducing a common, uniform way to manage all payments.  ...
(Date:7/23/2015)... 23, 2015 Aware, Inc. (NASDAQ: AWRE ), ... financial results for its second quarter ended June 30, 2015.  ... was $4.5 million, a decrease of 33% compared to $6.8 ... the second quarter of 2015 was $0.3 million, or $0.01 ... per diluted share, in the same period a year ago.  ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... 2011) - A new study has found that most patients ... recommended number of samples to diagnose celiac disease. The ... Endoscopy , analyzed a national database of biopsy specimens maintained ... patients had a biopsy of the small intestine, but only ...
... leaves can vary by a factor of 1,000 across plant species, ... new study by an international team of scientists led by UCLA ... In research federally funded by the National Science Foundation, the ... to dry soil because of their distinct vein systems. ...
... The Damon Runyon Cancer Research Foundation, a ... researchers, named 18 new Damon Runyon Fellows at ... recipients of this prestigious, three-year award are outstanding ... in the laboratories of leading senior investigators across ...
Cached Biology News:Low adherence to biopsy guidelines affects celiac disease diagnosis in the United States 2Being small has its advantages, if you are a leaf 2Being small has its advantages, if you are a leaf 3Being small has its advantages, if you are a leaf 4Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists 2Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists 3Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists 4Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists 5Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists 6
RABBIT ANTI HUMAN ATR (aa2122-2380) Immunogen: Human ATR peptide, amino acids 2122-2380...
RABBIT ANTI D-TYROSINE CONJUGATE...
UV LAMP 300 NM 8W T5, 1 EA. Category: Nucleid Acid Detection Systems....
Kit for Detection of Mitochondrial Membrane Potential...
Biology Products: